Pierre, N., Huynh-Thu, V. A., Baiwir, D., VIEUJEAN, S., Bequet, E., Reenaers, C., Van Kemseke, C., Salée, C., Massot, C., Fleron, M., Mazzucchelli, G., Trzpiot, L., Eppe, G., De Pauw, E., Louis, E., & Meuwis, M.-A. (02 February 2024). Distinct blood protein profiles associated with ileal and colonic ulcers in Crohn’s disease [Poster presentation]. Belgian Week of Gastroenterology 2024, Antwerp, Belgium. |
Adam, P., Salée, C., Stepniak, M., Loly, J.-P., VIEUJEAN, S., KROPP, S., Reenaers, C., Fonzé, F., Massot, C., BLETARD, N., COIMBRA MARQUES, C., DECKER, E., Delvenne, P., Louis, E., & Meuwis, M.-A. (2024). Characterization of the impact of NKCC1 in colorectal carcinogenesis [Paper presentation]. Belgian Week of Gastroenterology 2024. |
Dragoni, G., Innocenti, T., Amiot, A., Castiglione, F., Melotti, L., Festa, S., Savarino, E., Truyens, M., Argyriou, K., Noviello, D., Molnar, T., Bouillon, V., Bezzio, C., Eder, P., Fernandes, S., Kagramanova, A., Armuzzi, A., Oliveira, R., Viola, A., ... TOFA-poSTOP Study Group. (2024). Pre-operative exposure to tofacitinib is as safe as biologics in patients with ulcerative colitis undergoing colectomy: a multicentre observational study [Poster presentation]. European Crohn's and Colitis Organisation 2024. |
Holvoet, T., Brusselle, E., Verstockt, B., Lenfant, M., Julsgaard, M., Drobne, D., Thakor, A., Gordon, H., Molnar, T., Savarino, E., Ribaldone, D. G., Miheller, P., VIEUJEAN, S., Candel, I., Viso, M., Bettenworth, D., Eden, P., Issachar, A., & Lobaton, T. (2024). Safety and effectiveness of vedolizumab and ustekinumab in inflammatory bowel disease patients after liver transplantation for primary sclerosing cholangitis: results from an ECCO-confer case series [Poster presentation]. Belgian Week of Gastroenterology 2024, Antwerp, Belgium. |
Holvoet, T., Verstockt, B., Lenfant, M., Julsgaard, M., Drobne, D., Thakor, A., Gordon, H., Molnar, T., Savarino, E., Ribaldone, D. G., Miheller, P., VIEUJEAN, S., Candel, I., Menchen, V., Bettenworth, D., Eder, P., Issachar, A., & Lobaton, T. (2024). Safety and effectiveness of vedolizumab and ustekinumab in inflammatory bowel disease patients after liver transplantation for primary sclerosing cholangitis: results from an ECCO-confer case series [Poster presentation]. European Crohn's and Colitis Organisation 2024. |
MONIN, L., Reenaers, C., Grandfils, S., Latour, P., Van Kemseke, C., KROPP, S., Louis, E., & VIEUJEAN, S. (2024). Outcomes in patients stopping biologic during the first trimester of pregnancy : a retrospective monocentric study [Poster presentation]. Belgian Week of Gastroenterology 2024. |
MONIN, L., Reenaers, C., Grandfils, S., Latour, P., Van Kemseke, C., KROPP, S., Louis, E., & VIEUJEAN, S. (2024). Outcomes in patients stopping biologic during the first trimester of pregnancy : a retrospective monocentric study [Poster presentation]. European Crohn's and Colitis Organisation 2024. |
Pierre, N., Huynh-Thu, V. A., Baiwir, D., VIEUJEAN, S., Bequet, E., Reenaers, C., Van Kemseke, C., Salée, C., Massot, C., Fleron, M., Mazzucchelli, G., Trzpiot, L., Eppe, G., De Pauw, E., Louis, E., & Meuwis, M.-A. (2024). Distinct blood protein profiles associated with ileal and colonic ulcers in Crohn’s disease [Poster presentation]. European Crohn's and Colitis Organisation 2024, Stockholm, Sweden. |
Pierre, N., Huynh-Thu, V. A., Baiwir, D., VIEUJEAN, S., Bequet, E., Reenaers, C., Van Kemseke, C., Salée, C., Massot, C., Fleron, M., Mazzucchelli, G., Trzpiot, L., Eppe, G., De Pauw, E., Louis, E., & Meuwis, M.-A. (2024). Distinct blood protein profiles associated with ileal and colonic ulcers in Crohn’s disease [Paper presentation]. Belgian Week of Gastroenterology 2024. |
Reves, J., Roager Madsen, G., Burisch, J., Wong, C., Arebi, N., Bonnet-Dodel, M., Buisson, A., Gatt, K., Ellul, P., VIEUJEAN, S., Ordas, I., Duricova, D., Rodríguez-Lago, I., Sebastian, S., Mocanu, I., Kaimakliotis, I., Goldis, A., Hernandez, V., Nachury, M., ... CROCO Study Group. (2024). Disability in Crohn’s Disease Patients at diagnosis: Findings from the CROCO (Crohn´s Disease Cohort) study [Poster presentation]. European Crohn's and Colitis Organisation 2024, Stockholm, Sweden. |
Stepniak, M., Adam, P., Salée, C., Loly, J.-P., VIEUJEAN, S., Reenaers, C., Fonzé, F., Massot, C., COIMBRA MARQUES, C., DECKER, E., BLETARD, N., Delvenne, P., Speca, S., Louis, E., & Meuwis, M.-A. (2024). Study of the role of the epithelium in the initiation and progression of intestinal fibrosis in Ulcerative Colitis [Paper presentation]. Belgian Week of Gastroenterology 2024. |
Testa, G., Ribaldone, D. G., Verstockt, B., Molnar, T., Savarino, E., Schmidt, C., VIEUJEAN, S., Teich, N., Meianu, C., Juillerat, P., Grellier, N., & Lobaton, T. (2024). JAK inhibitors and S1P receptor modulators for the treatment of antibiotic refractory chronic pouchitis: an ECCO CONFER Multicentre Case Series [Poster presentation]. European Crohn's and Colitis Organisation 2024. |
Torres, J., Roager Madsen, G., Burisch, J., Wong, C., Arebi, N., Bonnet-Dodel, M., Buisson, A., Gatt, K., Ellul, P., VIEUJEAN, S., Ordas, I., Duricova, D., Rodríguez-Lago, I., Sebastian, S., Mocanu, I., Kaimakliotis, I., Goldis, A., Hernandez, V., Nachury, M., ... Torres, J. (2024). Bowel damage and its correlation with the disability index in patients with recently diagnosed Crohn´s Disease [Paper presentation]. European Crohn's and Colitis Organisation 2024, Stockholm, Sweden. |
Verstockt, B., Taelman, T., Vavricka, S., Zabana, Y., Lenfant, M., Macaigne, G., Maillard, M., Savarino, E., Teich, N., Kiudelis, V., de la Revilla Negro, J., Ribaldone, D. G., Barreiro-de Acosta, M., Wildt, S., Rivière, P., Fumery, M., Truyens, M., Amiot, A., Marsal, J., ... Julsgaard, M. (2024). Promising efficacy of biologicals and small molecules for microscopic colitis: results from a large real-life multicenter cohort [Paper presentation]. European Crohn's and Colitis Organisation 2024. |
VIEUJEAN, S., Desseaux, K., Laharie, D., Satsangi, J., Ding, N., Siegmund, B., D’Haens, G., Picon, L., Bossuyt, P., Vuitton, L., Irving, P., Viennot, S., Lamb, C., Pollok, R., Baert, F., Nachury, M., Fumery, M., Gilletta, C., Resche-Rigon, M., ... GETAID and the SPARE-Biocycle research group. (2024). No difference in progression of disability 2 years after stopping infliximab or immunosuppressant vs. continuing combo therapy in patients with CD in sustained steroid-free remission: a subanalysis of SPARE [Poster presentation]. European Crohn's and Colitis Organisation 2024, Stockholm, Sweden. |
VIEUJEAN, S., Desseaux, K., Laharie, D., Satsangi, J., Ding, N., Siegmund, B., D’Haens, G., Picon, L., Bossuyt, P., Vuitton, L., Irving, P., Viennot, S., Lamb, C., Pollok, R., Baert, F., Nachury, M., Fumery, M., Gilletta, C., Resche-Rigon, M., ... GETAID and the SPARE-Biocycle research group. (2024). No difference in progression of disability 2 years after stopping infliximab or immunosuppressant vs. continuing combination therapy in patients with CD in sustained steroid-free remission: a subanalysis of SPARE [Poster presentation]. Belgian Week of Gastroenterology 2024. |
Ribaldone, D. G., Vieujean, S., Mette, J., Armandi, A., Zingone, F., Savarino, E., Cañete, F., Aratari, A., Imperatore, N., Ramos, L., Plaza, R., Pugliese, D., Barberio, B., Drobne, D., & Chaparro, M. (2023). Non-hepatic solid organ transplant in patients with inflammatory bowel disease: an ECCO CONFER Multicentre Case Series. Journal of Crohn's and Colitis. doi:10.1093/ecco-jcc/jjad030 |
VIEUJEAN, S., Laharie, D., Buisson, A., Roblin, X., Fumery, M., Nancey, S., Wils, P., Altwegg, R., Seidel, L., Caron, B., & Peyrin-Biroulet, L. (2023). Histological healing induced by tofacitinib in ulcerative colitis: A multicentre study. Digestive and Liver Disease. doi:10.1016/j.dld.2023.11.022 |
Parigi, T. L., Vieujean, S., Paridaens, K., Dalgaard, K., Peyrin-Biroulet, L., & Danese, S. (19 November 2023). Efficacy, Safety, and Concerns on Microbiota Modulation, Antibiotics, Probiotics, and Fecal Microbial Transplant for Inflammatory Bowel Disease and Other Gastrointestinal Conditions: Results from an International Survey. Microorganisms, 11 (11), 2806. doi:10.3390/microorganisms11112806 |
Ribaldone, D. G., Testa, G., Verstockt, B., Molnar, T., Savarino, E., Schmidt, C., Vieujean, S., Teich, N., Meianu, C., Juillerat, P., Grellier, N., & Lobaton, T. (2023). Treatment of antibiotic refractory chronic pouchitis with JAK inhibitors and S1P receptor modulators: an ECCO CONFER Multicentre Case Series. Journal of Crohn's and Colitis. doi:10.1093/ecco-jcc/jjad194 |
Vieujean, S., Lindsay, J. O., D'Amico, F., Ahuja, V., Silverberg, M. S., Sood, A., Yamamoto-Furusho, J. K., Nagahori, M., Watanabe, M., Koutroubakis, I. E., Foteinogiannopoulou, K., Avni Biron, I., Walsh, A., Outtier, A., Nordestgaard, R. L. M., Abreu, M. T., Dubinsky, M., Siegel, C., Louis, E., ... Peyrin-Biroulet, L. (2023). Analysis of Clinical Trial Screen Failures in Inflammatory Bowel Diseases (IBD): Real World Results from the International Organization for the study of IBD. Journal of Crohn's and Colitis. doi:10.1093/ecco-jcc/jjad180 |
Muller, M., Broséus, J., Guilloteau, A., Wasse, S., Thiéblemont, C., Nancey, S., Cadiot, G., Amiot, A., Laharie, D., Vieujean, S., Bouhnik, Y., Martineau, C., Michiels, C., Hebuterne, X., Savoye, G., Franchimont, D., Seksik, P., Beaugerie, L., Maynadié, M., ... Peyrin-Biroulet, L. (2023). Lymphoma In Patients With Inflammatory Bowel Disease: A Multicenter Collaborative Study Between Getaid And Lysa. Journal of Crohn's and Colitis. doi:10.1093/ecco-jcc/jjad177 |
Pierre, N., VIEUJEAN, S., Meuwis, M.-A., & Louis, E. (2023). Définir la rémission biologique dans la maladie de Crohn. Medi-Sphere. |
Vieujean, S., Kotze, P. G., Netter, P., Germain, A., Louis, E., Danese, S., & Peyrin-Biroulet, L. (2023). Stemming the tide with ileocecal Crohn's disease: when is pharmacotherapy enough? Expert Opinion on Pharmacotherapy, 1 - 13. doi:10.1080/14656566.2023.2232726 |
Pierre, N., Vieujean, S., Peyrin-Biroulet, L., Meuwis, M.-A., & Louis, E. (2023). Defining biological remission in Crohn's disease: interest, challenges and future directions. Journal of Crohn's and Colitis. doi:10.1093/ecco-jcc/jjad086 |
Vieujean, S., Lindsay, J., Rubin, D., D’Amico, F., Ahuja, V., Silverberg, M., Sood, A., Yamamoto-Furusho, J., Nagahori, M., Watanabe, M., Koutroubakis, I., Foteinogiannopoulou, K., Walsh, A., Outtier, A., Abreu, M., Dubinsky, M., Siegel, C., Louis, E., Dotan, I., ... Peyrin-Biroulet, L. (06 May 2023). Analysis of Clinical Trial Screen Failures in IBD: Real World Results from the IOIBD [Poster presentation]. Digestive Disease Week. |
D’Amico, F., Vieujean, S., Caron, B., Peyrin-Biroulet, L., & Danese, S. (24 April 2023). Risk-Benefit of IBD Drugs: A Physicians and Patients Survey. Journal of Clinical Medicine, 12 (9), 3094. doi:10.3390/jcm12093094 |
Bonsack, O., Caron, B., Baumann, C., Heba, A. C., Vieujean, S., Arnone, D., Netter, P., Danese, S., Quilliot, D., & Peyrin-Biroulet, L. (2023). Food avoidance and fasting in patients with inflammatory bowel disease: Experience from the Nancy IBD nutrition clinic. United European Gastroenterology Journal. doi:10.1002/ueg2.12385 |
Loly, J.-P., Vieujean, S., Reenaers, C., Van Kemseke, C., Seidel, L., Louis, E., & Somja, J. (2023). In-Depth Assessment of Endoscopic Remission in Inflammatory Bowel Disease Treated by Anti-TNF or Vedolizumab. Inflammatory Bowel Diseases. doi:10.1093/ibd/izad066 |
Vieujean, S., Louis, E., Danese, S., & Peyrin-Biroulet, L. (2023). A critical review of ustekinumab for the treatment of active ulcerative colitis in adults. Expert Review of Gastroenterology and Hepatology, 1 - 18. doi:10.1080/17474124.2023.2194632 |
Bequet, E., Salée, C., BLETARD, N., Vieujean, S., Massot, C., Fonzé, F., Sarter, H., Ley, D., Colinet, S., Delvenne, P., Seghaye, M.-C., Louis, E., & Meuwis, M.-A. (March 2023). Characterization of Protein Disulfide Isomerases in adult and pediatric Crohn’s Disease and association with inflammation and fibrosis [Poster presentation]. 18th Congress of European Crohn's and Colitis Organisation 2023, Copenhagen, Denmark. |
Bequet, E., Salée, C., BLETARD, N., Vieujean, S., Massot, C., Fonzé, F., Sarter, H., Ley, D., Colinet, S., Delvenne, P., Seghaye, M.-C., Louis, E., & Meuwis, M.-A. (March 2023). Characterization of Protein Disulfide Isomerases in adult and pediatric Crohn’s Disease and association with inflammation and fibrosis [Poster presentation]. 35th Belgian Week of Gastroenterology 2023. |
Cremer, A., Mansour, A., Lobaton, T., Vieujean, S., Bossuyt, P., Rahier, J.-F., Baert, F., Dewit, O., Macken, E., Vijverman, A., Van Hootegem, P., Mana, F., Willandt, B., Humblet, E., D'Heygere, F., Verreth, A., El Nawar, A., Coenegrachts, J.-L., Dewit, S., ... Franchimont, D. (March 2023). Assessment of the one-year Efficacy and Safety of Tofacitinib in biologic-refractory patients with Ulcerative Colitis: a real-world Belgian cohort study [Paper presentation]. 35th Belgian Week of Gastroenterology 2023. |
D’Amico, F., Caron, B., Vieujean, S., Peyrin-Biroulet, L., & Danese, S. (March 2023). Risk-benefit assessment of IBD drugs: a physicians and patients survey [Poster presentation]. 18th Congress of European Crohn's and Colitis Organisation 2023. |
Gofflot, A., MONIN, L., Seidel, L., Reenaers, C., KROPP, S., Van Kemseke, C., Latour, P., Forthomme, B., Croisier, J.-L., Louis, E., & Vieujean, S. (March 2023). Impact of different types of physical activity in inflammatory bowel disease [Paper presentation]. 35th Belgian Week of Gastroenterology 2023. |
Gofflot, A., MONIN, L., Seidel, L., Reenaers, C., KROPP, S., Van Kemseke, C., Latour, P., Forthomme, B., Croisier, J.-L., Louis, E., & Vieujean, S. (March 2023). Impact of different types of physical activity in inflammatory bowel disease [Poster presentation]. 18th Congress of European Crohn's and Colitis Organisation 2023. |
Ribaldone, D. G., Vieujean, S., Julsgaard, M., Savarino, E., Canete, F., Aratari, A., Imperatore, N., Ramos, L., Plaza, R., Pugliese, D., Barberio, B., Drobne, D., & Chaparro, M. (March 2023). Solid organ transplant (with the exception of liver) in patients with inflammatory bowel disease: An ECCO CONFER Multicentre Case Series [Poster presentation]. 18th Congress of European Crohn's and Colitis Organisation 2023. |
Torres, J., Ellul, P., Vieujean, S., Ordas, I., Burisch, J., Mocanu, I., Duricova, D., Lago, I. R., Buisson, A., Goldis, A., Hernandez, V., Arebi, N., Kaimakliotis, I., Nachury, M., Fumery, M., Allocca, M., Pedersen, N., Barberio, B., Sebastian, S., ... Colombel, J.-F. (March 2023). Disability in newly diagnosed patients with Crohn´s Disease (CD): initial results from the prospective CROCO (Crohn´s Disease Cohort) Study [Poster presentation]. 18th Congress of European Crohn's and Colitis Organisation 2023. |
Verstock, B., Vieujean, S., Truyens, M., Julsgaard, M., Pugliese, D., Aslan, D., Prokopic, M., Lim, S., Vigano, C., Festa, S., Ralis, L., García, M. J., Plaza, R., Noviello, D., Savarino, E., Drobne, D., Imperatore, N., Ribaldone, D., Van Dongen, J., ... Barberio, B. (March 2023). Ustekinumab is the preferred biological agent in IBD patients with hidradenitis suppurativa failing anti-TNF therapy: results from a reallife multicenter cohort [Paper presentation]. 35th Belgian Week of Gastroenterology 2023. |
Verstockt, B., Vieujean, S., Truyens, M., Julsgaard, M., Pugliese, D., Aslan, D., Prokopic, M., Lim, S., Viganò, C., Festa, S., Ramos, L., Plaza, R., Noviello, D., Savarino, E., Drobne, D., Imperatore, N., Ribaldone, D. G., Van Dongen, J., Teich, N., ... Goren, I. (March 2023). Ustekinumab is the preferred biological agent in IBD patients with hidradenitis suppurativa failing anti-TNF therapy [Poster presentation]. 18th Congress of European Crohn's and Colitis Organisation 2023, Copenhague, Denmark. |
Vieujean, S., De Vos, M., D'Amico, F., Paridaens, K., Daftary, G., Peyrin-Biroulet, L., & Danese, S. (March 2023). Inflammatory bowel disease meets fertility: a physician and patient survey [Poster presentation]. 18th Congress of European Crohn's and Colitis Organisation 2023. |
Vieujean, S., GILLARD, R., Calvaer, F., Chayeb, M., Seidel, L., Reenaers, C., KROPP, S., Van Kemseke, C., Latour, P., Louis, E., & Meunier, P. (March 2023). Assessment of therapeutic response in Crohn’s disease by dynamic contrast enhanced MRI [Poster presentation]. 35th Belgian Week of Gastroenterology 2023. |
Vieujean, S., GILLARD, R., Calvaer, F., Chayeb, M., Seidel, L., Reenaers, C., KROPP, S., Van Kemseke, C., Latour, P., Louis, E., & Meunier, P. (March 2023). Assessment of therapeutic response in Crohn’s disease by dynamic contrast enhanced MRI [Poster presentation]. 35th Belgian Week of Gastroenterology 2023. |
Vieujean, S., Lindsay, J., Rubin, D., D’Amico, F., Ahuja, V., Silverberg, M., Sood, A., Yamamoto-Furusho, J. K., Nagahori, M., Watanabe, M., Koutroubakis, I. E., Foteinogiannopoulou, K., Walsh, A., Outtier, A., Abreu, M. T., Dubinsky, M., Siegel, C., Louis, E., Dotan, I., ... Peyrin-Biroulet, L. (March 2023). Analysis of Clinical Trial Screen Failures in IBD: Real World Results from the IOIBD [Poster presentation]. 18th Congress of European Crohn's and Colitis Organisation 2023. |
Vieujean, S., Lindsay, J., Rubin, D., D'Amico, F., Ahuja, V., Silverberg, M., Sood, A., Yamamoto-Furusho, J. K., Nagahori, M., Watanabe, M., Koutroubakis, I. E., Foteinogiannopoulou, K., Walsh, A., Outtier, A., Abreu, M. T., Dubinsky, M., Siegel, C., Louis, E., Dotan, I., ... Peyrin-Biroulet, L. (March 2023). Analysis of Clinical Trial Screen Failures in IBD: Real World Results from the IOIBD [Poster presentation]. 35th Belgian Week of Gastroenterology 2023. |
Lovinfosse, P., Vieujean, S., Louis, E., & Hustinx, R. (2023). Commentary to "[68 Ga]Ga-FAPI-04 PET/CT on assessing Crohn's disease intestinal lesions" by Chen and colleagues. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-023-06135-1 |
Vieujean, S., De Vos, M., D’Amico, F., Paridaens, K., Daftary, G., Dudkowiak, R., Peyrin-Biroulet, L., & Danese, S. (2023). Inflammatory bowel disease meets fertility: a physician and patient survey. Digestive and Liver Disease. doi:10.1016/j.dld.2023.01.149 |
Bequet, E., Salée, C., BLETARD, N., Vieujean, S., Massot, C., Fonzé, F., Sarter, H., Ley, D., Collinet, S., Seghaye, M.-C., Delvenne, P., Louis, E., & Meuwis, M.-A. (2023). Etude de la distribution de disulphides isomérases dans l’épithélium iléal et colique de maladies de Crohn sténosantes adultes et pédiatriques [Paper presentation]. Journées Francophones d'Hépato-gastroentérologie et d'Oncologie Digestive. |
Vieujean, S., De Vos, M., D'Amico, F., Paridaens, K., Daftary, G., Peyrin-Biroulet, L., & Danese, S. (2023). Inflammatory bowel disease meets fertility: a physician and patient survey [Poster presentation]. 35th Belgian Week of Gastroenterology 2023. |
Vieujean, S., De Vos, M., D'Amico, F., Paridaens, K., Daftary, G., Peyrin-Biroulet, L., & Danese, S. (2023). Inflammatory bowel disease meets fertility: a physician and patient survey [Poster presentation]. Digestive Disease Week, Chicago, United States. |
Vieujean, S., De Vos, M., Paridaens, K., Daftary, G. S., Danese, S., & Peyrin-Biroulet, L. (2023). Fertility and assisted reproductive technologies outcomes of women with non-surgically managed inflammatory bowel diseases: a systematic review. Journal of Crohn's and Colitis. doi:10.1093/ecco-jcc/jjac170 |
VIEUJEAN, S., GILLARD, R., Delanaye, P., Seidel, L., Bequet, E., Salée, C., Meuwis, M.-A., Massot, C., Pierre, N., Meunier, P., Cavalier, E., & Louis, E. (2023). Matrix gla protein, a potential marker of tissue remodelling and physiological ageing of the gut in crohn’s disease. Scandinavian Journal of Gastroenterology, 1-8. doi:10.1080/00365521.2023.2286913 |
Vieujean, S., & Louis, E. (2023). Precision Medicine and Drug Optimization in Adults Inflammatory Bowel Disease Patients. Therapeutic Advances in Gastroenterology. doi:10.1177/17562848231173331 |
Vieujean, S., Moens, A., Hassid, D., Rothfuss, K., Savarino, E., Vavricka, S. R., Reenaers, C., Jacobsen, B., Allez, M., Ferrante, M., Rahier, J. F., & ECCO CONFER investigators. (2023). Pneumocystis jirovecii pneumonia in patients with inflammatory bowel disease - A case series. Journal of Crohn's and Colitis. doi:10.1093/ecco-jcc/jjac153 |
Chevet, E., Bassal, F., Beq, S., Bonhomme, B., Boisteau, E., Calloch, J., Cazals-Hatem, D., Delom, F., Fessart, D., Evrard, S., Hrstka, R., hupp, T., Lièvre, A., Louis, E., Mariau, J., Meuwis, M.-A., Ogier-Denis, E., Paradis, V., Pernot, S., ... Vieujean, S. (2022). AGR2 protein expression in colorectal tumour epithelial compartment [letter to the editor]. Gut, 2022-328739. doi:10.1136/gutjnl-2022-328739 |
Vieujean, S., D'Amico, F., Netter, P., Danese, S., & Peyrin-Biroulet, L. (2022). Landscape of new drugs and targets in inflammatory bowel disease. United European Gastroenterology Journal. doi:10.1002/ueg2.12305 |
Vieujean, S., Caron, B., Haghnejad, V., Jouzeau, J.-Y., Netter, P., Heba, A.-C., Ndiaye, N. C., Moulin, D., Barreto, G., Danese, S., & Peyrin-Biroulet, L. (09 July 2022). Impact of the Exposome on the Epigenome in Inflammatory Bowel Disease Patients and Animal Models. International Journal of Molecular Sciences, 23 (14), 7611. doi:10.3390/ijms23147611 |
VIEUJEAN, S., Caron, B., Jairath, V., Benetos, A., Danese, S., LOUIS, E., & Peyrin-Biroulet, L. (22 May 2022). Is it time to include older adults in inflammatory bowel disease trials? A call for action. The Lancet Healthy Longevity, 3 (5), 356 - e366. doi:10.1016/S2666-7568(22)00060-5 |
Loly, J.-P., Vieujean, S., Reenaers, C., Van Kemseke, C., Seidel, L., Somja, J., & Louis, E. (March 2022). Remission state in inflammatory bowel disease patients on anti-TNF or vedolizumab: a confocal endomicroscopy study [Paper presentation]. 34th Belgian Week of Gastroenterology 2022. |
Reenaers, C., Vieujean, S., COIMBRA MARQUES, C., BOUTAFFALA, L., GILLARD, R., Meunier, P., & Louis, E. (March 2022). Efficacité et sécurité du traitement par cellules souches mésenchymateuses hématopoïétiques dans les lésions ano-périnéales de maladie de Crohn : résultats d’une étude prospective monocentrique [Paper presentation]. Journées Francophones D’hépato-Gastroenterologie Et D’oncologie Digestive. |
Reenaers, C., Vieujean, S., COIMBRA MARQUES, C., GILLARD, R., Meunier, P., BOUTAFFALA, L., & Louis, E. (March 2022). Efficacy and safety of bone marrow-derived mesenchymal stem cells in refractory perianal fistulae in Crohn's disease: results from a prospective monocentric study [Paper presentation]. 34th Belgian Week of Gastroenterology 2022. |
VIEUJEAN, S. (2022). The potential role of the epithelial cells and the mesenchymal stem cells in Crohn's disease fibrosis : from bedside to bench and back [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/290496 |
LOLY, J.-P., VIEUJEAN, S., REENAERS, C., VAN KEMSEKE, C., SEIDEL, L., SOMJA, J., & LOUIS, E. (01 January 2022). P234 Remission state in Inflammatory Bowel Disease patients on anti TNF or vedolizumab: a confocal endomicroscopy study. Journal of Crohn's and Colitis, 16 (Supplement_1), 283-i283. doi:10.1093/ecco-jcc/jjab232.361 |
MOREAU, A.-C., SEIDEL, L., VIEUJEAN, S., REENAERS, C., & LOUIS, E. (January 2022). Impact clinique de la vidéocapsule endoscopique du grêle dans les saignements digestifs inexpliqués. Etude rétrospective monocentrique. Revue Médicale de Liège, 77 (1), 25-31. |
Reenaers Dr, C., Vieujean, S., Coimbra, C., GILLARD, R., Meunier, P., BOUTAFFALA, L., & Louis, E. (01 January 2022). DOP31 Efficacy and safety of bone marrow-derived mesenchymal stem cells in refractory perianal fistulae in Crohn’s Disease: Results from a prospective monocentric study [Paper presentation]. 17th Congress of European Crohn's and Colitis Organisation. doi:10.1093/ecco-jcc/jjab232.070 |
VIEUJEAN, S., DELANAYE, P., SEIDEL, L., CAVALIER, E., Pierre, N., & LOUIS, E. (01 January 2022). P168 Matrix Gla protein, a potential marker of tissue remodelling and physiological ageing of the gut in Crohn’s Disease [Poster presentation]. European Crohn's and Colitis Organisation 2022. doi:10.1093/ecco-jcc/jjab232.296 |
VIEUJEAN, S., DELANAYE, P., SEIDEL, L., CAVALIER, E., Pierre, N., & LOUIS, E. (2022). Matrix Gla Protein, a potential marker of tissue remodelling and physiological ageing of the gut in Crohn's disease [Paper presentation]. Belgian Week of Gastroenterology 2022. |
VIEUJEAN, S., LOLY, J.-P., BOUTAFFALA, L., MEUNIER, P., REENAERS, C., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., BEGUIN, Y., & LOUIS, E. (2022). Mesenchymal Stem Cell Injection in Crohn's Disease Strictures: a phase I-II clinical study. Journal of Crohn's and Colitis, 16, 506-510. doi:10.1093/ecco-jcc/jjab154 |
VIEUJEAN, S., Hu, S., Bequet, E., SALEE, C., MASSOT, C., BLETARD, N., Pierre, N., Quesada Calvo, F., Baiwir, D., Mazzucchelli, G., De Pauw, E., COIMBRA MARQUES, C., DELVENNE, P., Rieder, F., LOUIS, E., & MEUWIS, M.-A. (October 2021). Potential Role of Epithelial Endoplasmic Reticulum Stress and Anterior Gradient Protein 2 Homolog in Crohn’s Disease Fibrosis. Journal of Crohn's and Colitis, 15 (10), 1737-1750. doi:10.1093/ecco-jcc/jjab061 |
VIEUJEAN, S., LOLY, J.-P., BOUTAFFALA, L., MEUNIER, P., REENAERS, C., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., BEGUIN, Y., & LOUIS, E. (October 2021). Local Mesenchymal Stem Cells injection in Crohn’s disease strictures: a phase I-II, open-label clinical study [Poster presentation]. United European Gastroenterology. |
VIEUJEAN, S., LATOUR, P., COIMBRA MARQUES, C., DELVENNE, P., LOUIS, E., & VAN KEMSEKE, C. (2021). Unusual intra-rectal “laterally spreading tumour” in immunosuppressed patient with ulcerative colitis. Acta Gastro-Enterologica Belgica. doi:10.51821/84.3.018 |
VIEUJEAN, S., Hu, S., Bequet, E., SALEE, C., MASSOT, C., BLETARD, N., Pierre, N., Quesada Calvo, F., Baiwir, D., Mazzucchelli, G., De Pauw, E., COIMBRA MARQUES, C., Delvenne, P., LOUIS, E., & MEUWIS, M.-A. (July 2021). Potential Role of Epithelial Protein Disulphide Isomerases in Crohn’s Disease Fibrosis [Poster presentation]. 16th Congress of European Crohn's and Colitis Organisation - Inflammatory Bowel Diseases 2021 Virtual. |
VIEUJEAN, S., LOLY, J.-P., BOUTAFFALA, L., Pariente, B., REENAERS, C., BRIQUET, A., LECHANTEUR, C., BEGUIN, Y., & LOUIS, E. (July 2021). Local Mesenchymal Stem Cells injection in Crohn’s disease strictures: a phase I-II, open-label clinical study [Poster presentation]. 16th Congress of European Crohn's and Colitis Organisation - Inflammatory Bowel Diseases 2021 Virtual. |
Vieujean, S., Hu, S., Bequet, E., SALEE, C., MASSOT, C., BLETARD, N., Pierre, N., Quesada Calvo, F., Baiwir, D., Mazzucchelli, G., De Pauw, E., COIMBRA MARQUES, C., DELVENNE, P., LOUIS, E., & MEUWIS, M.-A. (03 March 2021). Potential Role of Epithelial Protein Disulphide Isomerases in Crohn’s Disease Fibrosis [Paper presentation]. Belgian Week of Gastroenterology_33rd edition. |
Merli, A.-M., Vieujean, S., MASSOT, C., BLETARD, N., QUESADA CALVO, F., Baiwir, D., Mazzucchelli, G., Servais, L., Wéra, O., Oury, C., de Leval, L., Sempoux, C., Manzini, R., Bluemel, S., Scharl, M., Rogler, G., De Pauw, E., COIMBRA MARQUES, C., Colard, A., ... Meuwis, M.-A. (01 February 2021). Solute carrier family 12 member 2 as a proteomic and histological biomarker of dysplasia and neoplasia in ulcerative colitis. Journal of Crohn's and Colitis, 15 (2), 287-297. doi:10.1093/ecco-jcc/jjaa168 |
Monin, L., Dubois, S., REENAERS, C., VAN KEMSEKE, C., LATOUR, P., VAN DAELE, D., VIEUJEAN, S., SEIDEL, L., & Louis, E. (2021). Ustekinumab in bio-naïve and bio-failure Crohn's disease patients: Results from a « real-life » monocentric cohort. Digestive and Liver Disease. doi:10.1016/j.dld.2020.10.040 |
Pierre, N., Salée, C., Vieujean, S., Bequet, E., Merli, A.-M., Siegmund, B., Meuwis, M.-A., & Louis, E. (2021). Review article: distinctions between ileal and colonic Crohn's disease: from physiology to pathology. Alimentary Pharmacology and Therapeutics, 54 (6), 779-791. doi:10.1111/apt.16536 |
VIEUJEAN, S., Dauby, M., REMACLE, G., KRIDELKA, F., DEWANDRE, P.-Y., & CAPELLE, X. (2021). Rupture spontanée d’un anévrysme de l’artère splénique au cours du troisième trimestre de la grossesse. Revue Médicale de Liège. |
VIEUJEAN, S., COIBION, C., SEIDEL, L., LOUIS, E., & MEUNIER, P. (2020). Magnetic resonance enterography perfusion parameters reveal complex changes in affected and unaffected segments in Crohn's disease. Scandinavian Journal of Gastroenterology. doi:10.1080/00365521.2020.1802773 |
Cremer, A., Lobaton, T., VIEUJEAN, S., Bossuyt, P., Rahier, J.-F., Baert, F., Dewit, O., Macken, E., Somers, M., Vijverman, A., Deflandre, J., Van Hootegem, P., Mana, F., Willandt, B., Caenepeel, P., Humblet, E., D'Heygere, F., Verreth, A., El Nawar, A., ... Franchimont, D. (May 2020). Tofacitinib induces clinical and endoscopic remission in biologic refractory Ulcerative Colitis patients: A real-world Belgian cohort study [Poster presentation]. Digestive Disease Week (DDW), Chicago, United States. |
Cremer, A., Lobaton, T., VIEUJEAN, S., Bossuyt, P., Rahier, J.-F., Baert, F., Dewit, O., Macken, E., Somers, M., Vijverman, A., Deflandre, J., Van Hootegem, P., Mana, F., Willandt, B., Caenepeel, P., Humblet, E., D'Heygere, F., Verreth, A., El Nawar, A., ... Franchimont, D. (05 March 2020). Tofacitinib induces clinical and endoscopic remission in biologic refractory Ulcerative Colitis patients: A real-world Belgian cohort study [Paper presentation]. Belgian Week of Gastroenterology, Antwerp, Belgium. |
Vieujean, S., Hu, S., Bequet, E., Salee, C., Massot, C., BLETARD, N., Pierre, N., QUESADA CALVO, F., Baiwir, D., Mazzucchelli, G., De Pauw, E., Delvenne, P., Louis, E., & Meuwis, M.-A. (05 March 2020). Increased Endoplasmic Reticulum stress specific chaperones characterise CD fibrosis epithelium tissues and participates to in vitro induction of intestinal fibroblasts differentiation [Poster presentation]. Belgian Week of Gastroenterology, Antwerpen, Belgium. |
Merli, A.-M., Vieujean, S., MASSOT, C., BLETARD, N., QUESADA CALVO, F., Baiwir, D., Mazzucchelli, G., Servais, L., WERA, O., Oury, C., de Leval, L., Sempoux, C., Manzini, R., Scharl, M., Rogler, G., De Pauw, E., COIMBRA MARQUES, C., COLARD, A., Vijverman, A., ... LOUIS, E. (04 March 2020). SLC12A2 as a potential histological marker of ulcerative colitis associated colorectal dysplasia [Paper presentation]. Belgian Week of Gastroenterologyw, Antwerp, Belgium. |
Cremer, A., Lobaton, T., VIEUJEAN, S., Bossuyt, P., Rahier, J.-F., Baert, F., Dewit, O., Macken, E., Somers, M., Vijverman, A., Deflandre, J., Van Hootegem, P., Mana, F., Willandt, B., Caenepeel, P., Humblet, E., D'Heygere, F., Verreth, A., El Nawar, A., ... Franchimont, D. (14 February 2020). Tofacitinib induces clinical and endoscopic remission in biologic refractory Ulcerative Colitis patients: A real-world Belgian cohort study [Poster presentation]. European Crohn's and Colitis Organisation (ECCO), Vienna, Austria. |
Vieujean, S., Hu, S., Bequet, E., Salee, C., Massot, C., BLETARD, N., Pierre, N., Quesada Calvo, F., Baiwir, D., Mazzucchelli, G., De Pauw, E., Delvenne, P., LOUIS, E., & Meuwis, M.-A. (14 February 2020). Increased Endoplasmic Reticulum stress specific chaperones characterise CD fibrosis epithelium tissues and participate to in vitro induction of intestinal fibroblasts differentiation [Poster presentation]. European Crohn's and Colitis Organisation (ECCO), Vienna, Austria. |
VIEUJEAN, S., BURY, T., GASPARD, L., GIOT, J.-B., MAWEJA, S., LOUIS, E., & VAN KEMSEKE, C. (February 2019). Ganglionic tuberculosis in a Crohn’s disease patient treated by infliximab despite anti-tuberculosis chemoprophylaxis [Paper presentation]. Belgian Week of Gastroenterology 31st Edition - BWGE 2019. |
VIEUJEAN, S., MOENS, A., ROTHFUSS, K., SAVARINO, E., VAVRICKA, S., REENAERS, C., FERRANTE, M., & RAHIER, J.-F. (February 2019). Pneumocystis jirovecii pneumonia in IBD patients treated with immunomodulators [Poster presentation]. Belgian Week of Gastroenterology - 31th edition. |
VIEUJEAN, S., MOENS, A., ROTHFUSS, K., SAVARINO, E., VAVRICKA, S., REENAERS, C., FERRANTE, M., & RAHIER, J.-F. (February 2019). Pneumocystis jirovecii pneumonia in IBD patients treated with immunomodulator(s) [Poster presentation]. 14th Congress of ECCO. |
VIEUJEAN, S., LATOUR, P., COIMBRA MARQUES, C., LOUIS, E., & VAN KEMSEKE, C. (February 2018). Curious intra-rectal “laterally spreading tumor” in immunosuppressed patient with ulcerative colitis [Paper presentation]. Belgian Week of Gastroenterology 30th Edition - BWGE 2018. |
VIEUJEAN, S., LOUIS, E., & REENAERS, C. (February 2018). Immunosuppressive co-treatment with Infliximab and Adalimumab is not superior than anti-TNF monotherapy to prevent treatment failure over time in ulcerative colitis [Poster presentation]. 13th Congress of ECCO, Vienna, Austria. |
VIEUJEAN, S., LOUIS, E., & REENAERS, C. (February 2018). Immunosuppressive co-treatment with Infliximab and adalimumab is not superior than anti-TNF monotherapy to prevent treatment failure over time [Poster presentation]. 30th edition of Belgian Week of Gastroenterology. |
VIEUJEAN, S., LOUIS, E., & REENAERS, C. (February 2018). Étude dans la vie réelle de l’association d’un traitement immunosuppresseur avec l’Infliximab et l’Adalimumab dans la colite ulcéreuse [Poster presentation]. Journées Francophones d'Hépato-gastroentérologie et d'Oncologie Digestive. |
VIEUJEAN, S., LOUIS, E., & REENAERS, C. (October 2017). Immunosuppressive co-treatment with Infliximab and Adalimumab is not superior than anti-TNF monotherapy to prevent treatment failure over time in ulcerative colitis [Poster presentation]. 25th UEG week, Barcelona, Spain. |
VIEUJEAN, S., BRASSEUR, E., GHUYSEN, A., & D'ORIO, V. (17 January 2015). PROBLEMATIQUE DES LITS D’AVAL POUR LES ADMISSIONS VIA LES URGENCES [Poster presentation]. SYMPOSIUM OF THE BELGIAN SOCIETY OF EMERGENCY AND DISASTER MEDECINE, Bruxelles, Belgium. |